GlassScriptPhysician profile
Theodore E Fogwell
NPI 1679532840
$4,526.89
in general payments reported to CMS, 2019-2025
42 companies · $515 in 2025
The $515 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $289 · 2021: $1,811 · 2022: $541 · 2023: $611 · 2024: $317 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.28 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,193.99 | 2021-2025 | Exparel |
| Millicent US INC | $517.07 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Mayne Pharma Commercial LLC | $329.27 | 2021-2025 | Annovera, Nextstellis |
| Abbvie INC. | $285.45 | 2019-2024 | |
| Astellas Pharma US INC | $213.97 | 2023-2024 | Veozah |
| Pfizer INC. | $194.91 | 2019-2025 | |
| Novo Nordisk INC | $192.65 | 2023-2025 | Wegovy |
| Therapeuticsmd, INC. | $128.72 | 2019-2022 | |
| Coopersurgical, INC. | $97.47 | 2019 | |
| Avanos Medical | $92.22 | 2021 | |
| Minerva Surgical, INC | $86.51 | 2021-2023 | |
| Caldera Medical, INC | $80.00 | 2021 | |
| Myriad Women'S Health, INC. | $75.19 | 2023 | Myrisk |
| Shield Therapeutics INC | $68.45 | 2022-2023 | Accrufer |
| Aspira Women'S Health INC | $62.91 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Fogwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.